As of November 2024 Neurocrine Biosciences has 0 shares outstanding, a of - from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2022 | 95.80M | 1.27% |
2021 | 94.60M | 1.61% |
2020 | 93.10M | - |